PBM

Psyence Biomedical Ltd. PBM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PBM AZTR NKGN GTBP REVB PTIX LIPO ELAB SPRC DRMA
6M 8.92 % -66.70 % -84.13 % -67.40 % -84.89 % -11.11 % -75.10 % -17.61 % -24.47 % 508.45 %
YTD -75.69 % -76.15 % -97.11 % -75.05 % -95.69 % -55.98 % -81.13 % -87.76 % -47.94 % 210.79 %
1Y -93.87 % -80.60 % -92.74 % -63.33 % -96.68 % -59.13 % -83.61 % -87.64 % -7.94 % 224.81 %
3Y -99.91 % -99.93 % -99.65 % -98.53 % -99.99 % -90.48 % -89.57 % -99.69 % -99.19 % -97.41 %
5Y -99.91 % -99.93 % -99.65 % -99.39 % -100.00 % -97.47 % -89.57 % -99.69 % -99.83 % -99.65 %
10Y -99.91 % -99.93 % -99.65 % -100.00 % -100.00 % -97.47 % -89.57 % -99.69 % -99.83 % -99.65 %
From the beginning -99.91 % -99.93 % -99.65 % -100.00 % -100.00 % -97.47 % -89.57 % -99.69 % -99.83 % -99.65 %

Dividend

Protagenic Therapeutics, Inc.